Heart valve disease: Investigation by cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Myerson, Saul G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiovascular Magnetic Resonance; Flow quantification; Valve disease

Indexed keywords

AORTA ROOT; AORTA STENOSIS; BLOOD FLOW; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; GOLD STANDARD; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE; HEART SEPTUM DEFECT; HEART VALVE PROSTHESIS; HEART VALVE REGURGITATION; HEART VALVE STENOSIS; HEART VENTRICLE FUNCTION; HEART VENTRICLE VOLUME; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PULMONARY VALVE DISEASE; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE STENOSIS; RADIOCARDIOGRAPHY; REVIEW; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE STENOSIS; VALVULAR HEART DISEASE; HEART VALVE; HEMODYNAMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY;

HEART VALVE DISEASES; HEART VALVES; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 84860567357     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-7     Document Type: Review

References (78)

1. Planimetry of the aortic valve orifice area: comparison of multislice spiral computed tomography and magnetic resonance imaging. Westermann Y, Geigenmuller A, Elgeti T, Wagner M, Dushe S, Borges AC, Dohmen PM, Hein PA, Lembcke A, Eur J Radiol 2011 77 426 435 10.1016/j.ejrad.2009.08.014 19783394
2. Effects of turbulence on signal intensity in gradient echo images. Evans AJ, Blinder RA, Herfkens RJ, Spritzer CE, Kuethe DO, Fram EK, Hedlund LW, Invest Radiol 1988 23 512 518 10.1097/00004424-198807000-00006 3170139
3. Cine MR imaging of heart valve dysfunction with segmented true fast imaging with steady state free precession. Krombach GA, Kuhl H, Bucker A, Mahnken AH, Spuntrup E, Lipke C, Schroder J, Gunther RW, J Magn Reson Imaging 2004 19 59 67 10.1002/jmri.10428 14696221 (Pubitemid 38055730)
4. Diagnostic accuracy and estimation of the severity of valvular regurgitation from the signal void on cine magnetic resonance images. Wagner S, Auffermann W, Buser P, Lim TH, Kircher B, Pflugfelder P, Higgins CB, Am Heart J 1989 118 760 767 10.1016/0002-8703(89)90590-5 2801483 (Pubitemid 19242573)
5. Cine MR imaging of valvular heart disease: display and imaging parameters affect the size of the signal void caused by valvular regurgitation. Suzuki J, Caputo GR, Kondo C, Higgins CB, AJR Am J Roentgenol 1990 155 723 727 2119099 (Pubitemid 20305026)
6. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Jr. Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, J Am Coll Cardiol 2006 48 1 148 10.1016/j.jacc.2006.05.021 16875962 (Pubitemid 44109952)
7. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, Pennell DJ, Eur Heart J 2000 21 1387 1396 10.1053/euhj.2000.2011 10952828 (Pubitemid 30599134)
8. Assessment of left ventricular mass by cardiovascular magnetic resonance. Myerson SG, Bellenger NG, Pennell DJ, Hypertension 2002 39 750 755 10.1161/hy0302.104674 11897757 (Pubitemid 34252869)
9. Right and left ventricular volume measurements in an animal heart model in vitro: first experiences with cardiac MRI at 1.0 T. Koch JA, Poll LW, Godehardt E, Korbmacher B, Modder U, Eur Radiol 2000 10 455 458 10.1007/s003300050075 10756995 (Pubitemid 30145758)
10. Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession. Thiele H, Paetsch I, Schnackenburg B, Bornstedt A, Grebe O, Wellnhofer E, Schuler G, Fleck E, Nagel E, J Cardiovasc Magn Reson 2002 4 327 339 10.1081/JCMR-120013298 12234104 (Pubitemid 34983286)
11. Evaluation of left ventricular volumes and ejection fraction using fast steady-state cine MR imaging: comparison with left ventricular angiography. Ichikawa Y, Sakuma H, Kitagawa K, Ishida N, Takeda K, Uemura S, Motoyasu M, Nakano T, Nozaki A, J Cardiovasc Magn Reson 2003 5 333 342 10.1081/JCMR- 120019422 12765112 (Pubitemid 36569952)
12. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Myerson SG, Montgomery HE, World MJ, Pennell DJ, Hypertension 2002 40 673 678 10.1161/01.HYP.0000036401.99908.DB 12411461 (Pubitemid 35278604)
13. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ, Am J Cardiol 2002 90 29 34 10.1016/S0002-9149(02)02381-0 12088775 (Pubitemid 34671198)
14. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO, J Am Soc Echocardiogr 2003 16 1091 1110 14566308
15. Quantitative assessment of aortic regurgitation by magnetic resonance imaging. Globits S, Frank H, Mayr H, Neuhold A, Glogar D, Eur Heart J 1992 13 78 83 1577036
16. Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. Gatehouse PD, Keegan J, Crowe LA, Masood S, Mohiaddin RH, Kreitner KF, Firmin DN, Eur Radiol 2005 15 2172 2184 10.1007/s00330-005-2829-3 16003509 (Pubitemid 41403517)
17. Flow measurement by magnetic resonance: a unique asset worth optimising. Kilner PJ, Gatehouse PD, Firmin DN, J Cardiovasc Magn Reson 2007 9 723 728 10.1080/10976640701465090 17613655
18. Quantification of the aortic regurgitant volume with magnetic resonance phase velocity mapping: a clinical investigation of the importance of imaging slice location. Chatzimavroudis GP, Oshinski JN, Franch RH, Pettigrew RI, Walker PG, Yoganathan AP, J Heart Valve Dis 1998 7 94 101 9502146 (Pubitemid 28085660)
19. Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. Hundley WG, Li HF, Hillis LD, Meshack BM, Lange RA, Willard JE, Landau C, Peshock RM, Am J Cardiol 1995 75 1250 1255 10.1016/S0002-9149(99)80771-1 7778549
20. Quantification of aortic regurgitation by magnetic resonance velocity mapping. Sondergaard L, Lindvig K, Hildebrandt P, Thomsen C, Stahlberg F, Joen T, Henriksen O, Am Heart J 1993 125 1081 1090 10.1016/0002-8703(93)90117-R 8465731 (Pubitemid 23117341)
21. Mitral and aortic valvular flow: quantification with MR phase mapping. Sondergaard L, Thomsen C, Stahlberg F, Gymoese E, Lindvig K, Hildebrandt P, Henriksen O, J Magn Reson Imaging 1992 2 295 302 10.1002/jmri.1880020308 1627864
22. MRI phase contrast velocity and flow errors in turbulent stenotic jets. O'Brien KR, Cowan BR, Jain M, Stewart RA, Kerr AJ, Young AA, J Magn Reson Imaging 2008 28 210 218 10.1002/jmri.21395 18581344 (Pubitemid 351956485)
23. Baseline correction of phase contrast images improves quantification of blood flow in the great vessels. Chernobelsky A, Shubayev O, Comeau CR, Wolff SD, J Cardiovasc Magn Reson 2007 9 681 685 10.1080/10976640601187588 17578724 (Pubitemid 46956903)
24. Improved accuracy in flow mapping of congenital heart disease using stationary phantom technique. Miller TA, Landes AB, Moran AM, J Cardiovasc Magn Reson 2009 11 52 10.1186/1532-429X-11-52 20003318
25. Flow measurement by cardiovascular magnetic resonance: a multi-centre multi-vendor study of background phase offset errors that can compromise the accuracy of derived regurgitant or shunt flow measurements. Gatehouse PD, Rolf MP, Graves MJ, Hofman MB, Totman J, Werner B, Quest RA, Liu Y, von Spiczak J, Dieringer M, Firmin DN, van Rossum A, Lombardi M, Schwitter J, Schulz-Menger J, Kilner PJ, J Cardiovasc Magn Reson 2010 12 5 10.1186/1532-429X-12-5 20074359
26. The application of phase shifts in NMR for flow measurement. Firmin DN, Nayler GL, Kilner PJ, Longmore DB, Magn Reson Med 1990 14 230 241 10.1002/mrm.1910140209 2345505 (Pubitemid 20248608)
27. 3D MR flow analysis in realistic rapid-prototyping model systems of the thoracic aorta: comparison with in vivo data and computational fluid dynamics in identical vessel geometries. Canstein C, Cachot P, Faust A, Stalder AF, Bock J, Frydrychowicz A, Kuffer J, Hennig J, Markl M, Magn Reson Med 2008 59 535 546 10.1002/mrm.21331 18306406 (Pubitemid 351348225)
28. Comparison of flow patterns in ascending aortic aneurysms and volunteers using four-dimensional magnetic resonance velocity mapping. Hope TA, Markl M, Wigstrom L, Alley MT, Miller DC, Herfkens RJ, J Magn Reson Imaging 2007 26 1471 1479 10.1002/jmri.21082 17968892 (Pubitemid 350291274)
29. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, J Cardiovasc Magn Reson 2008 10 35 10.1186/1532-429X-10-35 18605997
30. Absolute assessment of aortic valve stenosis by planimetry using cardiovascular magnetic resonance imaging: comparison with transesophageal echocardiography, transthoracic echocardiography, and cardiac catheterisation. Reant P, Lederlin M, Lafitte S, Serri K, Montaudon M, Corneloup O, Roudaut R, Laurent F, Eur J Radiol 2006 59 276 283 10.1016/j.ejrad.2006.02.011 16873006 (Pubitemid 44093158)
31. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? John AS, Dill T, Brandt RR, Rau M, Ricken W, Bachmann G, Hamm CW, J Am Coll Cardiol 2003 42 519 526 10.1016/S0735-1097(03)00707-1 12906983 (Pubitemid 36951721)
32. Correlation of aortic valve area obtained by the velocity-encoded phase contrast continuity method to direct planimetry using cardiovascular magnetic resonance. Tanaka K, Makaryus AN, Wolff SD, J Cardiovasc Magn Reson 2007 9 799 805 10.1080/10976640701545479 17891618 (Pubitemid 47463908)
33. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Kilner PJ, Manzara CC, Mohiaddin RH, Pennell DJ, Sutton MG, Firmin DN, Underwood SR, Longmore DB, Circulation 1993 87 1239 1248 8462150 (Pubitemid 23110396)
34. Valve area and cardiac output in aortic stenosis: quantification by magnetic resonance velocity mapping. Sondergaard L, Hildebrandt P, Lindvig K, Thomsen C, Stahlberg F, Kassis E, Henriksen O, Am Heart J 1993 126 1156 1164 10.1016/0002-8703(93)90669-Z 8237760 (Pubitemid 23330418)
35. Comparison between cardiovascular magnetic resonance and transthoracic doppler echocardiography for the estimation of effective orifice area in aortic stenosis. Garcia J, Kadem L, Larose E, Clavel MA, Pibarot P, J Cardiovasc Magn Reson 2011 13 25 10.1186/1532-429X-13-25 21527021
36. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S, Riegger G, Luchner A, Heart 2006 92 1447 1451 10.1136/hrt.2005.079392 16606864 (Pubitemid 44578839)
37. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J, Circulation 2003 107 984 991 10.1161/01.CIR.0000051865.66123.B7 12600911 (Pubitemid 36258721)
38. Mid-wall fibrosis is an independent predictor of mortality in patients with aortic stenosis (abstr). Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurado F, Mohiaddin R, Pepper JR, Pennell DJ, Newby D, Prasad S, Heart 2011 97 94
39. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Dulce MC, Mostbeck GH, O'Sullivan M, Cheitlin M, Caputo GR, Higgins CB, Radiology 1992 185 235 240 1523315
40. Aortic regurgitation: quantitation with MR imaging velocity mapping. Honda N, Machida K, Hashimoto M, Mamiya T, Takahashi T, Kamano T, Kashimada A, Inoue Y, Tanaka S, Yoshimoto N, Radiology 1993 186 189 194 8416562 (Pubitemid 23005487)
41. Heart motion adapted cine phase-contrast flow measurements through the aortic valve. Kozerke S, Scheidegger MB, Pedersen EM, Boesiger P, Magn Reson Med 1999 42 970 978 10.1002/(SICI)1522-2594(199911)42:5<970::AID-MRM18>3.0. CO;2-I 10542357 (Pubitemid 29521488)
42. Evaluation of the precision of magnetic resonance phase velocity mapping for blood flow measurements. Chatzimavroudis GP, Oshinski JN, Franch RH, Walker PG, Yoganathan AP, Pettigrew RI, J Cardiovasc Magn Reson 2001 3 11 19 10.1081/JCMR-100000142 11545135 (Pubitemid 32410397)
43. Aortic regurgitation quantification with cardiovascular magnetic resonance predicts clinical outcome. Myerson SG, D'Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM, Banning AP, Christiansen JP, Neubauer S, Heart 2011 97 93 94
44. Aortic regurgitation: time to reassess timing of valve replacement? Bonow RO, JACC Cardiovasc Imaging 2011 4 231 233 10.1016/j.jcmg.2011.01.006 21414569
45. Magnetic resonance assessment of aortic and mitral regurgitation. Underwood SR, Klipstein RH, Firmin DN, Fox KM, Poole-Wilson PA, Rees RS, Longmore DB, Br Heart J 1986 56 455 462 10.1136/hrt.56.5.455 3790381 (Pubitemid 17174617)
46. Assessment of functional anatomy of the mitral valve in patients with mitral regurgitation with cine magnetic resonance imaging: comparison with transesophageal echocardiography and surgical results. Stork A, Franzen O, Ruschewski H, Detter C, Mullerleile K, Bansmann PM, Adam G, Lund GK, Eur Radiol 2007 17 3189 3198 10.1007/s00330-007-0671-5 17549489 (Pubitemid 350142344)
47. Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. Chan KM, Wage R, Symmonds K, Rahman-Haley S, Mohiaddin RH, Firmin DN, Pepper JR, Pennell DJ, Kilner PJ, J Cardiovasc Magn Reson 2008 10 61 10.1186/1532-429X-10-61 19102740
48. Cardiovascular Magnetic Resonance for Direct Assessment of Anatomic Regurgitant Orifice in Mitral Regurgitation. Buchner S, Debl K, Poschenrieder F, Feuerbach S, Riegger G, Luchner A, Djavidani B, Circ Cardiovasc Imaging 2008 1 148 155 10.1161/CIRCIMAGING.107.753103 19808532
49. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. Fujita N, Chazouilleres AF, Hartiala JJ, O'Sullivan M, Heidenreich P, Kaplan JD, Sakuma H, Foster E, Caputo GR, Higgins CB, J Am Coll Cardiol 1994 23 951 958 10.1016/0735-1097(94)90642-4 8106701 (Pubitemid 24090882)
50. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. Gelfand EV, Hughes S, Hauser TH, Yeon SB, Goepfert L, Kissinger KV, Rofsky NM, Manning WJ, J Cardiovasc Magn Reson 2006 8 503 507 10.1080/10976640600604856 16755839
51. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. Kon MW, Myerson SG, Moat NE, Pennell DJ, J Heart Valve Dis 2004 13 600 607 15311866
52. Prediction of clinical outcome in asymptomatic mitral regurgitation using CMR. D'Arcy J, Christiansen JP, Mohiaddin R, Karamitsos TD, Francis JM, Neubauer S, Myerson SG, European Society of Cardiology Congress; 27-31 Aug 2011; Paris 2011 22272703
53. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ, N Engl J Med 2005 352 875 883 10.1056/NEJMoa041451 15745978 (Pubitemid 40300296)
54. Direct and indirect quantification of mitral regurgitation with cardiovascular magnetic resonance, and the effect of heart rate variability. Myerson SG, Francis JM, Neubauer S, MAGMA 2010 23 243 249 10.1007/s10334-010- 0222-y 20632070
55. Planimetry of mitral valve stenosis by magnetic resonance imaging. Djavidani B, Debl K, Lenhart M, Seitz J, Paetzel C, Schmid FX, Nitz WR, Feuerbach S, Riegger G, Luchner A, J Am Coll Cardiol 2005 45 2048 2053 10.1016/j.jacc.2005.03.036 15963408 (Pubitemid 40814130)
56. Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound. Lin SJ, Brown PA, Watkins MP, Williams TA, Lehr KA, Liu W, Lanza GM, Wickline SA, Caruthers SD, J Am Coll Cardiol 2004 44 133 137 10.1016/j.jacc.2004.03.038 15234421 (Pubitemid 38968471)
57. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Taliercio CP, Taylor CL, Bailey KR, Seward JB, J Am Soc Echocardiogr 1990 3 54 63 2310593
58. Surgery insight: late complications following repair of tetralogy of Fallot and related surgical strategies for management. Karamlou T, McCrindle BW, Williams WG, Nat Clin Pract Cardiovasc Med 2006 3 611 622 10.1038/ncpcardio0682 17063166 (Pubitemid 44614922)
59. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Rebergen SA, Chin JG, Ottenkamp J, van der Wall EE, de Roos A, Circulation 1993 88 2257 2266 8222120 (Pubitemid 23326106)
60. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Geva T, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006 11 22
61. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. Vliegen HW, van Straten A, de Roos A, Roest AA, Schoof PH, Zwinderman AH, Ottenkamp J, van der Wall EE, Hazekamp MG, Circulation 2002 106 1703 1707 10.1161/01.CIR.0000030995.59403.F8 12270866
62. Doppler-echocardiographic assessment of pulmonary regurgitation in adults with repaired tetralogy of Fallot: comparison with cardiovascular magnetic resonance imaging. Li W, Davlouros PA, Kilner PJ, Pennell DJ, Gibson D, Henein MY, Gatzoulis MA, Am Heart J 2004 147 165 172 10.1016/S0002-8703(03)00527-1 14691436 (Pubitemid 38037414)
63. Pulmonary regurgitation after tetralogy of Fallot repair: clinical features, sequelae, and timing of pulmonary valve replacement. Ammash NM, Dearani JA, Burkhart HM, Connolly HM, Congenit Heart Dis 2007 2 386 403 10.1111/j.1747-0803.2007.00131.x 18377431 (Pubitemid 350142841)
64. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM, Bouma BJ, Zwinderman AH, Hazekamp MG, de Roos A, Mulder BJ, Circulation 2007 116 545 551 10.1161/CIRCULATIONAHA.106.659664 17620511 (Pubitemid 47450263)
65. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Frigiola A, Redington AN, Cullen S, Vogel M, Circulation 2004 110 I153 157 15364855
66. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, Bonhoeffer P, Circulation 2008 117 1964 1972 10.1161/CIRCULATIONAHA.107.735779 18391109 (Pubitemid 351543472)
67. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. Schievano S, Coats L, Migliavacca F, Norman W, Frigiola A, Deanfield J, Bonhoeffer P, Taylor AM, J Cardiovasc Magn Reson 2007 9 687 695 10.1080/10976640601187596 17578725 (Pubitemid 46956908)
68. Sequential magnetic resonance monitoring of pulmonary flow with endovascular stents placed across the pulmonary valve in growing Swine. Kuehne T, Saeed M, Reddy G, Akbari H, Gleason K, Turner D, Teitel D, Moore P, Higgins CB, Circulation 2001 104 2363 2368 10.1161/hc4401.098472 11696479 (Pubitemid 33049522)
69. Tricuspid regurgitation in patients with repaired Tetralogy of Fallot and its relation to right ventricular dilatation. Mahle WT, Parks WJ, Fyfe DA, Sallee D, Am J Cardiol 2003 92 643 645 10.1016/S0002-9149(03)00746-X 12943899 (Pubitemid 37013431)
70. Comparison of magnetic resonance imaging with echocardiography and radionuclide angiography in assessing cardiac function and anatomy following Mustard's operation for transposition of the great arteries. Rees S, Somerville J, Warnes C, Underwood R, Firmin D, Klipstein R, Longmore D, Am J Cardiol 1988 61 1316 1322 10.1016/0002-9149(88)91176-9 3376893
71. MR imaging of Ebstein's anomaly of the tricuspid valve. Choi YH, Park JH, Choe YH, Yoo SJ, AJR Am J Roentgenol 1994 163 539 543 8079839
72. Ebstein's anomaly presenting in adulthood: the role of cine magnetic resonance imaging in diagnosis. Eustace S, Kruskal JB, Hartnell GG, Clin Radiol 1994 49 690 692 10.1016/S0009-9260(05)82661-3 7955830 (Pubitemid 24309625)
73. MR imaging of metallic implants and materials: a compilation of the literature. Shellock FG, AJR Am J Roentgenol 1988 151 811 814 3048071
74. Reference Manual for Magnetic Resonance Safety, Implants and Devices. Shellock F, Los Angeles: Biomedical Research Publishing Group 2011 2011
75. Assessment of prosthetic aortic valve performance by magnetic resonance velocity imaging. Botnar R, Nagel E, Scheidegger MB, Pedersen EM, Hess O, Boesiger P, Magma 2000 10 18 26 10.1007/BF02613108 10697222 (Pubitemid 30095833)
76. Prosthetic heart valve evaluation by magnetic resonance imaging. Hasenkam JM, Ringgaard S, Houlind K, Botnar RM, Stodkilde-Jorgensen H, Boesiger P, Pedersen EM, Eur J Cardiothorac Surg 1999 16 300 305 10.1016/S1010-7940(99) 00215-8 10554848 (Pubitemid 29443966)
77. Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses. von Knobelsdorff-Brenkenhoff F, Rudolph A, Wassmuth R, Bohl S, Buschmann EE, Abdel-Aty H, Dietz R, Schulz-Menger J, Circ Cardiovasc Imaging 2009 2 397 404 392 p following 404 10.1161/CIRCIMAGING.108. 840967 19808628
78. Magnetic Resonance-Derived 3-Dimensional Blood Flow Patterns in the Main Pulmonary Artery as a Marker of Pulmonary Hypertension and a Measure of Elevated Mean Pulmonary Arterial Pressure. Reiter G, Reiter U, Kovacs G, Kainz B, Schmidt K, Maier R, Olschewski H, Rienmueller R, Circ Cardiovasc Imaging 2008 1 23 30 10.1161/CIRCIMAGING.108.780247 19808511